About Venneos
Venneos is a company based in Stuttgart (Germany) founded in 2014 by David Wehner, Ralf Zeitler, and Jonas Lehmann. It operates as a B2B. Venneos has raised $1.12 million across 2 funding rounds from investors including Max-Planck-Gesellschaft, Born2Grow and High-Tech Gründerfonds. Venneos operates in a competitive market with competitors including Mekonos, MicroX Labs, Redbud Labs, Neo Nanotech and Pi Mems, among others.
- Headquarter Stuttgart, Germany
- Founders David Wehner, Ralf Zeitler, Jonas Lehmann
- SectorsHealthcare
- Website venneos.com
- Total Equity Funding$1.12M (USD)
in 2 rounds
- InvestorsMax-Planck-Gesellschaft
& 2 more
Funding Insights of Venneos
Venneos has successfully raised a total of $1.12M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.12M
- Total Rounds 2
- First Round $1.12M
(Sep 2015)
- Investors Count 3
All 2 funding rounds of Venneos with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2017 | – | Series A | – | Born2Grow, Max-Planck-Gesellschaft | – |
| Sep 2015 | $1.12M | Seed | – | Max-Planck-Gesellschaft, HTGF | – |
3 investors in total: 3 institutional.
Investors in Venneos
Venneos has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Max-Planck-Gesellschaft, Born2Grow and High-Tech Gründerfonds.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | born2grow.de | - | |
Early-stage investments are made in high-tech startups by HTGF. | – | htgf.de | Bonn, Germany | |
Ombudsman services for scientific misconduct in research are provided confidentially. | 1948 | mpg.de | Munich, Germany |
Investor details for Venneos
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Venneos
3 people are tracked at Venneos (3 in leadership).
| Name | Role | Group |
|---|---|---|
David Wehner | Co-Founder, MD | Leadership |
Ralf Zeitler | Co-Founder, MD | Leadership |
Jonas Lehmann | Co-Founder | Leadership |
Complete people profiles for Venneos
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Venneos
3 dated milestones of Venneos across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Venneos is founded.
- Funding First funding round of $1.1M.
- Funding Latest funding round, Series A,.
Competitors of Venneos
Venneos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mekonos, MicroX Labs, Redbud Labs, Neo Nanotech and Pi Mems, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mekonos.com | 2016 | Palo Alto, United States | $29.6M | – | Silicon-based nanomachine chips are developed for cell engineering applications. | |
| microxlabs.com | 2013 | Bengaluru, India | $63,446 | – | MEMS-based biochips are developed for blood cell counting. | |
| redbudlabs.com | 2010 | Chapel Hill, United States | $304,995 | 20 | Microfluidic platforms for biosensing and sample processing are manufactured. | |
| neonanotech.com | 2016 | Yuseong, South Korea | – | – | MEMS-based biochips are manufactured for disease diagnosis and sample processing. | |
| pimems.com | 2012 | Santa Barbara, United States | – | – | Titanium-based MEMS devices are developed for microelectronic thermal solutions. | |
| finalspark.com | 2014 | Vevey, Switzerland | – | – | Develops advanced artificial general intelligence systems for various applications. | |
| ivdchip.com | 2018 | Zhubei, Taiwan | – | – | Microfluidic chips are manufactured for biomedical sensors and drug detection. |
Detailed competitors of Venneos
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Venneos
10 companies that operate in the same segment as Venneos (Imaging Diagnostics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Handheld ultrasound devices are developed for whole-body medical imaging. | 2011 | Guilford, Connecticut, United States | USD 350 M | USD 97.61 M | 190 | |
Technology tools and systems for molecular scale are developed. | 1959 | Abingdon, Oxfordshire, United Kingdom | – | USD 648.1 M | – | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.17 M | – | 242 | |
Manufacturer of imaging and surgical products | 1919 | Tokyo, Tokyo, Japan | – | USD 6.49 B | 35,933 | |
Ultrasound images are analyzed via AI-based software provided by Exo. | 2015 | Redwood City, California, United States | USD 463.39 M | – | – | |
Planar X-ray radiology products for diagnostic imaging are supplied. | 2000 | Oxford, Oxfordshire, United Kingdom | USD 43.43 M | USD 1.04 M | 50 | |
Digital X-ray sources are developed by Nanox for cloud-based diagnostics. | 2004 | Jerusalem, Jerusalem District, Israel | USD 110.72 M | USD 13.02 M | 165 | |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies. | 2007 | Los Angeles, California, United States | USD 59.64 M | – | – | |
Portable wireless ultrasound systems are developed for medical imaging. | 2014 | Burnaby, British Columbia, Canada | USD 21.87 M | – | – | |
Portable MRI systems are manufactured for medical professionals. | 2014 | New York, New York, United States | – | USD 13.56 M | 111 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Venneos
Venneos was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Venneos is headquartered in Stuttgart, Germany. It is registered at Stuttgart, Baden-wurttemberg, Germany.
Venneos is a funded company, having raised a total of $1.12M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.12M, raised on Sep 2015.
Venneos, backed by 1117528.0 from Born2Grow, Max-Planck-Gesellschaft, HTGF, focuses on providing healthcare solutions, advancing biotech innovations, medical imaging, and cell analysis systems. Provides a silicon chip-based imaging system for analyzing biological cells. Driving innovation, growth, and excellence in its industry sectors.
Venneos's top competitors include Mekonos, MicroX Labs and Redbud Labs.
Venneos has 3 investors. Key investors include Max-Planck-Gesellschaft, Born2Grow, and High-Tech Gründerfonds.